U.K. directs more than $141M into medical innovation efforts

07/31/2013 | PharmaTimes (U.K.)

The U.K. government will infuse more than $141 million into the country's health sector in an effort to become a global leader in innovation. The support includes about $39.3 million to the Biomedical Catalyst, an initiative designed to bring medical innovations more quickly to market; about $57.7 million to a new National Biologics Manufacturing Centre; and millions to fund competitions targeting specific health issues.

View Full Article in:

PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA